Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Pediatric lung transplant specialist Christian Benden, MD, described the future for children who need lung transplants: fewer ...
Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...
Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results